Indivior · Health Care
INDV
$40.54
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.Indivior是一家美国制药公司，最初于1994年作为利洁时集团的分部成立，并于2014年12月从该公司分拆，专注于阿片类药物成瘾的替代产品。
Mixed profile混合特征
Mid cap中盘
$5B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线，预计将在约 1–3 个交易日内出现买入触发。
Key Statistics关键统计
Price价格
$40.54
3.1% below 52-week high低于52周高点 3.1%
Market Cap市值
$5B
Normal volume正常成交量
P/E Ratio市盈率
24.1x
28.9x sector median
Beta贝塔
0.40
Moves about 0.4x the market波动幅度约为市场的 0.4 倍
RSI (14)RSI（14）
56
Neutral zone中性区域
Next Earnings下次财报
2026-07-30 (11d)
Volatility Rank波动率分位
27th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
8.6% of float
Performance价格表现
| Period周期 | INDV | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +0.1% | -1.5% | Beat the index by 1.6 points跑赢指数 1.6 个百分点 |
| 1 Month近1月 | +6.9% | +0.6% | Beat the index by 6.3 points跑赢指数 6.3 个百分点 |
| 3 Months近3月 | +24.0% | +4.7% | Beat the index by 19.3 points跑赢指数 19.3 个百分点 |
| 6 Months近6月 | +24.6% | +7.8% | Beat the index by 16.8 points跑赢指数 16.8 个百分点 |
| Year to date年初至今 | +13.5% | +9.1% | Beat the index by 4.4 points跑赢指数 4.4 个百分点 |
| 1 Year近1年 | +150.9% | +19.4% | Beat the index by 131.5 points跑赢指数 131.5 个百分点 |
| 3 Years近3年 | +74.8% | +69.4% | Beat the index by 5.4 points跑赢指数 5.4 个百分点 |
Technicals技术面
RSI (14)RSI（14）
56
Neutral zone中性区域
vs 50-day相对50日均线
+4.7% vs 50-day avg
vs 200-day相对200日均线
+20.5% vs 200-day avg
Volatility rank波动率分位
27th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$40.23
Don't chase above不追高于
$40.78
Stop止损
$37.93
Buy soon — on confirmation即将买入 — 待确认
Earnings财务业绩
11
days until next report天后公布财报
2026-07-30
Estimates being raised — 4 analysts预期上调 — 4 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | INDV | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 24.14x | 28.92 | 64% |
| P/S市销率 | 4.09x | 3.02 | 36% |
| Earnings yield盈利收益率 | 4.14% | 2.72 | 74% |
| FCF yield自由现金流收益率 | -1.83% | 3.94 | 10% |
| Shareholder yield股东收益率 | 0.22% | 1.89 | 15% |
| EV/EBITDA企业价值/EBITDA | 19.10x | 18.21 | 46% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 4.3%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 8100.0%
Free Cash Flow自由现金流
Margins利润率
-214.3%Return on Equity股本回报率
17.5%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 0.46 |
| Current ratio流动比率 | 0.71 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $11.0M |
| Stock-based comp股权薪酬 | $26.0M |
Piotroski皮奥特罗斯基 3/8
Altman Z阿尔特曼Z: safe (3.5)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 39% of its sector on blended multiples综合估值倍数低于行业内 39% 的公司
Beta市场敏感度
0.40×
0.21×3×
Moves about 0.4× the market波动幅度约为市场的 0.4 倍
Financial Health财务健康
3/8
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: +$0.2M net (6 buyers, 0 sellers)+$0.2M 净值（6 买家，0 卖家）
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Soros Fund Management | B | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 15, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 10, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
INDV StochRSI turned up from oversoldINDV StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $40.89.StochRSI重回20上方 — 下行动量趋缓的最早预警。$40.89。
Jul 7, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
INDV took relative-strength leadershipINDV 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $40.83.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$40.83。
Jul 6, 2026
INDV daily MACD crossed downINDV 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $39.99.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$39.99。
Jul 2, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jun 29, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有
Showing last 15 of显示最近15条，共 235 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.14
Value价值
-1.0
Profitability盈利能力
+2.9
Quality质量
-2.8
Investment资本投入
+1.0
Shareholder payout股东回报
-1.0
Low volatility低波动
-0.1
Low market beta低市场敏感度
+0.6
Earnings quality盈利质量
-3.0
Short interest空头兴趣
-0.5
Company Profile公司档案
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.Indivior是一家美国制药公司，最初于1994年作为利洁时集团的分部成立，并于2014年12月从该公司分拆，专注于阿片类药物成瘾的替代产品。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。